《Table 5 Studies included for use of plasmapheresis in acute liver failure and acute-on-chronic live

《Table 5 Studies included for use of plasmapheresis in acute liver failure and acute-on-chronic live   提示：宽带有限、当前游客访问压缩模式
本系列图表出处文件名：随高清版一同展现
《Plasma exchange in patients with acute and acute-on-chronic liver failure: A systematic review》


  1. 获取 高清版本忘记账户？点击这里登录
  1. 下载图表忘记账户？点击这里登录

We included studies ranging from case reports to randomized control trials that have been published till 30 March，2019.We excluded abstracts in this review and have restricted to only studies in English.We excluded studies with insufficient information concerning our outcomes of interest and areas of comparison:e.g.，survival，the volume of plasma exchange and type of product exchanged.We included studies with only human participants diagnosed with liver failure who underwent plasma exchange，with or without other alternative liver support systems.There were no restrictions on the dose，duration，and type of plasma exchange（Table1 for PICOS criteria）.A PRISMA checklist was also used to guide the development of the systematic review.

图表编号XD00129034700    严禁用于非法目的
绘制时间2020.01.14
作者Eunice Xiang-Xuan Tan、Min-Xian Wang、Junxiong Pang、Guan-Huei Lee
绘制单位National University Health System、Centre for Infectious Disease Epidemiology and Research, Saw Swee Hock School of Public Health, National University of Singapore、Centre for Infectious Disease Epidemiology and Research, Saw Swee Hock School of Public Heal
更多格式高清、无水印（增值服务）

相关图表

  1. 《Table 1 Summary of the main characteristics of the 4 studies included in the meta-analysis》2018.06.01
  2. 《Table 2 Studies included for study of plasmapheresis in acute liver failure in adults》2020.01.14
  3. 《Table 5 Studies included for use of plasmapheresis in acute liver failure and acute-on-chronic liver failure in adults》2020.01.14
  4. 《Table 5 Studies included for use of plasmapheresis in acute liver failure and acute-on-chronic liver failure in adults》2020.01.14
  5. 《Table 3 Studies included in for study of plasmapheresis in acute liver failure in pediatric cohort》2020.01.14
  6. 《Table 3 Studies included in for study of plasmapheresis in acute liver failure in pediatric cohort》2020.01.14
  7. 《Table 4 Studies included for study of plasmapheresis in acute-on-chronic liver failure》2020.01.14
  8. 《Table 2 Studies included for study of plasmapheresis in acute liver failure in adults》2020.01.14
  9. 《Table 2 Studies included for study of plasmapheresis in acute liver failure in adults》2020.01.14
  10. 《Table 2 Studies included for study of plasmapheresis in acute liver failure in adults》2020.01.14
  11. 《Table 1 Characteristics of all studies included in this meta-analysis(arranged alphabetically by first author’s last nam》2019.10.07
  12. 《Table 1 Demographics of patients with inflammatory bowel disease included in the studies》2019.07.28
  13. 《Table 1 Characteristics of the studies included in the meta-analysis》2019.05.21
  14. 《Table 2 Characteristics of included studies:Vitamin D treatment and evaluating bone health in children with inflammatory》2019.01.22
  15. 《Table 1 Characteristics of included studies:Evaluating vitamin D treatment in children with inflammatory bowel disease》2019.01.22
  16. 《Table.General characteristics of studies on DCAG regimen included in the Meta-analysis》2019.04.20
  17. 《Table 1 Basic information for the 28 studies included in the meta-analysis》2019.01.30
  18. 《Table 1 Basic information for the 28 studies included in the meta-analysis》2019.01.30
  19. 《Table 1Characteristics of the studies included in the meta-analysis.》2018.12.15
  20. 《表2 纳入研究PHC患者的预后生存情况Table 2 Prognosis of PHC patients in included studies》2018.06.30

随机翻阅

《表1 北拉萨地体白垩纪实测剖面信息表》 《表4 补喂亮氨酸对伊犁马血浆α-酮异己酸浓度的影响》 《表1 能谱仪检测出的元素及其质量含量》 《表4 试样实际的化学成分》 《表5 训练后的置信规则库》 《表5 未经冻融的花岗岩试样矿物成分含量》 《表1 不同护理模式下腰椎间盘突出症患者临床指标比较[±s, n (%) ]》 《表1 响应面设计因素与水平》 《表1 两组受检者各项体检满意度调查结果分析[n (%) ]》 《表3 PIA与非PIA患者MRI影像特征分析[n (%) ]》